Plus Therapeutics PSTV Q1 2025 Annual earnings
Reported May 30, 2025 · After market close
Revenue$1.1MMiss by $424.3K
EPS-$0.56Miss by $0.31
Revenue estimate$1.5M
EPS estimate-$0.25
Next report
Aug 13, 2026 (In 2 weeks)Revenue estimate$1.1M
EPS estimate-$0.88
Versus estimates
Revenue
Diluted EPS
Ask the moment Plus Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Plus Therapeutics report Q1 2025 earnings?
- Plus Therapeutics (PSTV) reported Q1 2025 earnings on May 30, 2025 after market close.
- What were Plus Therapeutics's Q1 2025 revenue and EPS?
- Plus Therapeutics reported revenue of $1.1M and eps of $-0.56 for Q1 2025.
- Did Plus Therapeutics beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $1.5M by $424.3K. EPS missed the consensus estimate of $-0.25 by $0.31.
- How did Plus Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 36.9% from $1.7M a year earlier and eps grew 25.3% from $-0.75.
- Where can I find Plus Therapeutics's Q1 2025 SEC filings?
- You can read the 10-K periodic report (0000950170-25-047698) directly on SEC EDGAR. The filing index links above go to sec.gov.